|
WO2005105826A1
|
|
Tyropeptin a analogue
|
|
WO2005111055A1
|
|
Novel antibiotic kigamicins and use thereof
|
|
KR20050103216A
|
|
Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
|
|
US2005131061A1
|
|
Angiogenesis inhibitors
|
|
AU2003303775A1
|
|
Novel physiologically active substance rs-k3574 and process for producing the same
|
|
WO2004057011A1
|
|
Antibiotics caprazamycins d, g, d1 and g1 and process for producing the same
|
|
CA2430967A1
|
|
Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
|
|
US6939892B2
|
|
Compositions for treating or preventing malaria and method of treating malaria
|
|
WO0146451A1
|
|
Migrastatin, process for producing the same and medicinal compositions
|
|
AU6729400A
|
|
Macrolide antibiotics and treatment of pasteurellosis
|
|
CA2388050A1
|
|
Antibiotic caprazamycins and process for producing the same
|
|
CA2361624A1
|
|
5-glycosyloxy-6-hydroxynaphtho[2,3-f]quinoline-7,12-dione having anticancer activities
|
|
EP1142900A1
|
|
Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same
|
|
CA2310400A1
|
|
Novel physiologically active substance sulphostin, process for producing the same, and use thereof
|
|
US6245734B1
|
|
Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same
|
|
WO9844916A1
|
|
Preventives and remedies for ulcerous colitis and/or crohn's disease
|
|
US5798387A
|
|
Amino acid derivatives
|
|
EP0761678A1
|
|
Fluorine-containing anthracycline derivatives having hydroxyl group(s) mono- or di-o-aminoalkanoylated in the sugar moiety thereof
|
|
US5773607A
|
|
Processes for preparing 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
|
|
WO9524412A1
|
|
Novel anthracycline derivatives containing trifluoromethylated sugar unit
|
